SafeOp Surgical Files for 10th Patent, Extending Capabilities of its EPAD™ Intraoperative Neuromonitoring Platform

SafeOp Surgical, Inc. (“SafeOp”), a privately held medical device company, today announced that it has filed its tenth patent application for innovations surrounding the monitoring and real-time detection of motor nerve thresholds during surgery. SafeOp developed and markets the EPAD™ system, a revolutionary neuromonitoring platform that enables the detection of nerve damage and post-operative residual paralysis during surgical procedures. This latest filing is for the added capability to stimulate nerves during surgery to rapidly detect responses that help the surgical team identify the proximity and health of nearby nerves. SafeOp already holds or has provisional patents for detection of peripheral nerve injury using somatosensory evoked potentials, as well as signal processing and high specificity in alerting to signal change, and on neuromuscular junction testing and spinal cord stimulator paddle placement in one or more of the United States, European Union, Australia, Japan and China. [ABSTRACT FROM PUBLISHER]